goeasy Has Stopped Telling Us When the Book Grows Again
A third cut to the loan-book outlook, a capital-return program on indefinite hold, and a credit story that has quietly become a covenant story
GSY.TO · Earnings Call · 2026-11-11
The Recovery That Keeps Sliding Right
goeasy is twenty years into lending to Canadians with non-prime credit scores, and 2026 is the year it stopped growing. Third-quarter revenue fell 18.2% year over year to $372 million, the gross consumer loan book contracted 10% to $4.88 billion, and adjusted diluted earnings came in at a loss of $0.94 a share. That is the second consecutive quarter of sequential deterioration from an already negative base. The company's framing is that this is deliberate — a six-point plan announced in March to rebuild balance-sheet health, shrink the merchant-originated LendCare book and re-concentrate on direct-to-consumer originations through easyfinancial.
Fine. But plans come with timelines, and this one keeps moving. On the April call the promise was explicit: the book would decline in the first half "and then returning to some growth in the second half of the year to hit our year-end target of being roughly flat." By August that had softened to guidance for an ending book "roughly consistent with Q2." By this week it was $4.6–4.8 billion — below the $4.88 billion just reported. Patrick Ens conceded the point without being asked twice:
we have updated our year-end guidance twice. So our expectations have evolved as the year has evolved... our driving force on how much lending to do is really dictated by our estimation of the available profitable lending to be done.
That is an honest answer and a revealing one. The reason the book won't grow is not liquidity — it is that management no longer believes profitable lending is available at the volume it once assumed. Notably, the anticipated re-expansion into merchant channels is off the table: "we're not pursuing those at this time." The mix shift toward direct-to-consumer is real — 63.3% of the portfolio versus 53.6% a year ago — but it is happening by subtraction, not addition.
Credit Was the Story. Now It's the Covenants.
The most telling change this quarter is in what the company's own language has elevated. For most of 2025 the vocabulary was borrower assistance tools, early-stage delinquency, interest receivable, late-stage arrears. This quarter the top of the list is credit facility, banking syndicate, and facility covenants — a funding narrative displacing a credit narrative. That is a downgrade in subject matter, not an upgrade.
The facts behind it: the securitization warehouse was renewed on September 29, rightsized down from $1.12 billion to $910 million, with draws conditional on newly originated assets until the revolver is renegotiated. The $550 million revolver sits undrawn and matures July 2027, and management is now in active talks to extend it and amend covenants. Felix Wu was clear on urgency: “the revolver credit facility matures in July of 2027. Our goal is to address this sooner, much sooner than the actual maturity date.” — Felix Wu · 2026-11-11
And the thing management has stopped talking about entirely is capital return. Dividends and share repurchases are "suspended indefinitely" under covenant restrictions. For a company whose keyword history once carried things like payout ratio and dividend increase, that silence is the loudest line on the call.
There is a macro confluence here that is not company-specific. Canada raised rates on October 28 — the first hike in over three years — with unemployment at 6.7% and inflation at 3%-plus all quarter. Against a global tape where higher cost of capital has been a persistent decliner and rising interest rate environments has been a top market theme, a levered non-prime lender with 85% unsecured drawn debt carries that sensitivity on both sides of the ledger: funding cost and borrower stress.
The Reserve Is Doing the Talking
Strip out the accounting and the operating quarter was closer to breakeven. Strip it back in and the company lost money. The swing factor was the allowance for expected credit losses: a $41.6 million release in Q2 reversed into a $16.7 million build in Q3, with the reserve rate rising from 9.99% to 10.59%. Patrick Ens called that reversal "a major contributor to the quarter-over-quarter reduction in earnings." Net charge-offs improved 150 basis points to 15.2%, yet the reserve sits at barely two-thirds of the loss rate — a gap Jaeme Gloyn pressed on, and one Felix Wu answered with forecast horizon rather than arithmetic.
More consequential: the LendCare IFRS 9 material weakness identified at year-end is still not remediated. On the August call Felix described being "near the end of the first phase and starting the second phase as the second group with internal audit." This week: “we are moving into the phase of control testing and demonstrating sustainable positive results in our control test.” — Felix Wu · 2026-11-11 That is eleven months for a move from phase one to phase two. Remediation efforts are expected to run "throughout the remainder of fiscal 2026" — a timeline that has itself slipped once already.
What's Left in the Tank
Delinquencies rose 70 basis points quarter over quarter, with the 1-to-30-day bucket at 6.3% from 6.1%. Management's explanation — an "increased focus on cash collections" pushing early-stage balances up while late-stage improves — is the identical explanation offered in August. Consumer insolvencies moderated slightly; that is the one genuine green shoot.
Ens was refreshingly direct about the arithmetic that matters: “the highest leverage item is expanding what we would refer to as risk-adjusted margin, which is top line revenue yield minus credit loss rates.” — Patrick Ens · 2026-11-11 At roughly 27.7% yield less 15% losses the company is near 12%, and he conceded the target is "far enough north of that, that we have quite a bit of work to do." The new hire, Chief Credit Risk and Data Officer Mark Snyder, offered the most substantive forward-looking comment on the call — deeper use of bureau and banking transaction data to sharpen risk-adjusted returns — but two months in, that is a promise, not a number.
The recurring tell is the "binding constraint" line. In August: “the binding constraint for us at this point is more about where we see profitable returns... we're not constrained from a capital or funding perspective.” — Patrick Ens, CEO · 2026-08-07 This week, near-verbatim: “the binding constraint is just ensuring that the underwriting we're doing is going to be value additive... We don't have any current liquidity constraints from a growth perspective.” — Patrick Ens · 2026-11-11 Two quarters, one script, and in between the loan book got smaller again.
This is a credible management team managing a genuinely hard hand — the deleveraging is real, cash from operations before net principal written was $607 million, cash rose $179.7 million, and the lever to slow originations is genuine. But the story today is not a turnaround inflecting. It is a company that has declined to tell investors when the loan book grows again, has a control deficiency still open eleven months on, has capital return frozen, and is negotiating covenant relief from a position it describes as strength. The market can price a plan with a date on it. It cannot price one that keeps getting re-dated.